Spectrum Pharmaceuticals ...

NASDAQ: SPPI · Real-Time Price · USD
1.02
-0.01 (-0.97%)
At close: Jul 31, 2023, 9:56 PM

Spectrum Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
15.62M 10.11M n/a 39K n/a n/a n/a n/a n/a
Cost of Revenue
1.06M 1.79M 3K 42K n/a n/a n/a n/a n/a
Gross Profit
14.55M 8.32M -3K -3K n/a n/a n/a n/a n/a
Operating Income
-4.87M -11.64M -21.6M -25.39M -14.06M -36.85M -33.09M -44.07M -33.69M
Interest Income
559K 615K 128K 117K 11K 42K 11K 26K 84K
Pretax Income
-5.01M -11.73M -21.91M -29.03M -15.39M -39.76M -33.07M -49.92M -35.68M
Net Income
-5.14M -8.94M -21.93M -29.05M -15.4M -39.71M -33.08M -50.13M -35.7M
Selling & General & Admin
14M 11.3M 8.26M 9.38M 9.87M 18.89M 12.24M 14.96M 14.31M
Research & Development
5.42M 8.67M 13.34M 16.01M 4.19M 17.96M 20.85M 29.11M 19.37M
Other Expenses
n/a n/a n/a n/a n/a n/a 9K n/a n/a
Operating Expenses
19.42M 19.97M 21.6M 25.39M 14.06M 36.85M 33.09M 44.07M 33.69M
Interest Expense
943K 901K 128K 117K 11K n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
20.48M 21.76M 21.6M 25.39M 14.06M 36.85M 33.09M 44.07M 33.69M
Income Tax Expense
137K -2.79M 16K 13K 16K -5K n/a 16K -7K
Shares Outstanding (Basic)
201.92M 183.24M 188.36M 175.57M 169.74M 154.68M 159.26M 155.24M 145.37M
Shares Outstanding (Diluted)
201.92M 183.24M 188.36M 175.57M 169.74M 154.68M 159.26M 155.24M 145.37M
EPS (Basic)
-0.03 -0.05 -0.12 -0.17 -0.09 -0.26 -0.21 -0.32 -0.25
EPS (Diluted)
-0.03 -0.05 -0.12 -0.17 -0.09 -0.26 -0.21 -0.32 -0.25
EBITDA
-4.06M -10.83M -21.6M -25.39M -13.99M -36.85M -33.02M -44M -33.62M
EBIT
-4.2M -10.54M -21.79M -28.91M -15.38M -36.85M -33.09M -44.07M -33.69M
Depreciation & Amortization
807K 817K 53K 74K 73K 74K 74K 73K 65K